Assessing the outcomes in patients with nonconvulsive status epilepticus: Nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity

Journal of Clinical Neurophysiology

Volumn 16, Issue 4, 1999, Pages 341-352

  Kaplan, Peter W ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Diagnosis; Morbidity; Nonconvulsive status; Prognosis outcome; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE;

ARTICLE; COMA; COMORBIDITY; COMPLEX PARTIAL SEIZURE; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; GRAND MAL SEIZURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

BEHAVIOR; CONSCIOUSNESS; ELECTROENCEPHALOGRAPHY; HUMANS; MENTAL HEALTH; MORBIDITY; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 0032806740     PISSN: 07360258     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004691-199907000-00006     Document Type: Article

References (67)

1. Aicardi J, Chevrie JJ. Consequences of status epilepticus in infants and children. In: Delgado-Escueta AV, Wasterlain CG, Teriman DM, Porter RJ, eds. Status epilepticus: mechanisms of brain damage and treatment. New York: Raven Press, 1983:115-25. (Advances in neurology; vol 34.)
2. Aicardi J, Chevrie JJ. Consequences of status epilepticus in infants and children. In: Delgado-Escueta AV, Wasterlain CG, Teriman DM, Porter RJ, eds. Status epilepticus: mechanisms of brain damage and treatment. New York: Raven Press, 1983:115-25. Advances in neurology; vol 34.)
3. Al-Lozi MT, Kaplan PW. The grey zone of non-convulsive status epilepticus. Epilepsia 1991;32(S3):93.
4. Aminoff MJ. Do nonconvulsive seizures damage the brain? -No. Arch Neurol 1998;55:119-120.
5. Cockerell OC, Walker CM, Sander JWAS, et al. Complex partial status epilepticus: a recurrent problem. J Neurol Neurosurg Psychiatry 1994;57:835-7.
6. DeGiorgio CM, Heck CN, Rabinowicz AL, et al. Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology 1999;52:746-9.
7. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39:833-40.
8. Dodrill CB, Wilensky AJ. Intellectual impairment as an outcome of status epilepticus. Neurology 1990;40:23-7.
9. Drislane FW. Nonconvulsive status epilepticus in patients with cancer. Clin Neurol Neurosurg 1994;96:314-18.
10. Drislane FW, Schomer DL. Clinical implications of generalized electrographic status epilepticus. Epilepsy Res 1994;19:111-21.
11. Drislane F. Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16:323-31.
12. Dunne JW, Summers OA, Stewart-Wynne EG. Nonconvulsive status epilepticus. A prospective study in an adult general hospital. Q J Med 1987;238:117-26.
13. Earnest MP, Marx JA, Drury LR. Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. JAMA 1983;249:762-5.
14. Engel J, Jr., Ludwig BI, Fetell M. Prolonged partial complex status epilepticus: EEG and behavioral observations. Neurology 1978; 28:863-9.
15. Gastaut H, Roger A. Sur la signification de certain fugues épileptiques: état de mal temporal. Rev Neurol 1956;94:298-301.
16. Gellerman GL, Martinex C. Fatal ventricular fibrillation following intravenous sodium diphenylhydantoin therapy. JAMA 1967;200: 161-2.
17. Gökyiǧit A, Çalişkan A. Diffuse spike-wave status of 9-year duration without behavioral change or intellectual decline. Epilepsia 1995; 36:210-13.
18. Goldschlager AW, Karliner JS. Ventricular standstill after intravenous diphenylhydantoin. Am Heart J 1967;74:410-12.
19. Granner MA, Lee SI. Nonconvulsive status epilepticus: EEG analysis in a large series. Epilepsia 1994;35:42-7.
20. Handforth A, Cheng JT, Mandelkern MA, Treiman DM. Markedly increased mesiotemporal lobe metabolism in a case with PLEDs: further evidence that PLEDs are manifestation of partial status epilepticus. Epilepsia 1994;35:876-81.
21. Hanna DR. Purple glove syndrome: a complication of intravenous phenytoin. J Neurosci Nurs 1992;24:340-5.
22. Hilkens PHE, de Weerd AW. Nonconvulsive status epilepticus as cause for focal neurological deficit. Acta Neurol Scand 1995;92:193-7.
23. Hosford DA. Animal models of nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16:306-13.
24. Kaplan PW. Non-convulsive status epilepticus: to lump or to split? American Epilepsy Society-Annual Meeting, New Orleans, December 5, 1994. Epilepsia 1994;35(suppl 8):9.
25. Kaplan PW. Nonconvulsive status epilepticus. Semin Neurol 1996a; 16:33-40.
26. Kaplan PW, Nonconvulsive status epilepticus in the Emergency Room. Epilepsia 1996b;37:643-50.
27. Kaplan PW. Functional outcome following nonconvulsive status epilepticus. Epilepsia 1997;38(suppl 8):224.
28. Kaplan PW. Nonconvulsive status epilepticus. In: Kaplan P, ed. Neurologic disease in women. New York: Demos Medical Publishing, 1998;422-5.
29. Kilarski DJ, Buchanan C, Von Behren L. Soft-tissue damage associated with intravenous phenytoin. N Engl J Med 1984;311:145-6.
30. Kirshner HS, Hughes T, Fakhoury T, et al. Aphasia secondary to partial status epilepticus of the basal temporal language area. Neurology 1995;45:1616-18.
31. Krumholz A, Sung GY, Fisher RS, et al. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 1995;45:1449-504.
32. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992;29:483-8.
33. Labar D, Barrera J, Solomon G, et al. Nonconvulsive status epilepticus in the elderly: a case series and a review of the literature. J Epilepsy 1998;11:74-8.
34. Lee SI. Nonconvulsive status epilepticus - ictal confusion in later life. Arch Neurol 1985;42:778-81.
35. Lennox WG. The treatment of epilepsy. Med Clin North Am 1945:29: 1114-28.
36. Leppik IE, Derivan AT, Homan RW, Walker J, et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-4.
37. Levy RJ, Krall RL. Treatment of status epilepticus with lorazepam. Arch Neurol 1984;41:605-11.
38. Litt B, Wityk RJ, Hertz SH, et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998;39:1194-1202.
39. Louis S, Kutt H, McDowell F. The cardiocirculatory changes caused by intravenous Dilantin and its solvent. Am Heart J 1967;74:523-9.
40. Meldrum BS. Metabolic factors during prolonged seizures and their relation to nerve cell death. In: Escueta AV, Wasterlain CG, Treiman D, Porter R, eds. Status epilepticus. New York: Raven Press, 1983;261-75. (Advances in Neurology; vol 34.)
41. Meldrum BS. Metabolic factors during prolonged seizures and their relation to nerve cell death. In: Escueta AV, Wasterlain CG, Treiman D, Porter R, eds. Status epilepticus. New York: Raven Press, 1983;261-75. (Advances in Neurology; vol 34.)
42. Meldrum BS, Vigoraux RA, Brierley JB. Systemic factors and epileptic brain damage: prolonged seizures in paralyzed artificially ventilated baboons. Arch Neurol 1973;29:82-7.
43. Mikati MA, Lee WL, DeLong GR. Protracted epileptiform encephalopathy: an unusual form of partial complex status epilepticus. Epilepsia 1985;26:563-71.
44. Nevander G, Ingvar M, Auer RN, et al. Status epilepticus in well-oxgenated rats causes neuronal necrosis. Ann Neurol 1985;18: 281-90.
45. Olney JW, de Gubareff T, Sloviter RS. "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. II. Ultrastructural analysis of acute hippocampal pathology. Brain Res Bull 1983;10:699-712.
46. Olney JW, Rhee V, Ho OL. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 1974;77:507-12.
47. Orr RA, Dimand RJ, Venkataraman ST, et al. Diazepam and intubation in emergency treatment of seizures in children. Ann Emerg Med 1991;20:1009-13.
48. Privitera M, Hoffman M, Moore JL, et al. EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilepsy Res 1994;18:155-66.
49. Rao VK, Feldman PD, Dibbell DG. Extravasation injury to the hand by intravenous phenytoin. J Neurosurg 1988;68:967-9.
50. Rohr-le-Floch J, Gauthier G, Beaumanoir A. États confusionelles d'origine épileptique: interêt de l'EEG fait en urgence. Rev Neurol 1988;144:425-36.
51. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998;26:947-56.
52. Shorvon SD. Complex partial status epilepticus. In: Status epilepticus: its clinical features and treatment in children and adults. Cambridge, UK: Cambridge University Press, 1994;116.
53. Sloviter RS. "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant paths. I. Acute electrophysiological and light microscopic studies. Brain Res Bull 1983;10: 675-97.
54. Sloviter RS, Dempster DW. "Epileptic" brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not GABA or acetylcholine. Brain Res Bull 1985;15:39-60.
55. So EL, Ruggles KH, Ahmann PA, Trudeau SK, et al. Clinical significance and outcome of subclinical status epilepticus in adults. J Epilepsy 1995;8:11-15.
56. Strain FM, Tasker RAR. Hippocampal damage produced by domoic acid in mice. Neuroscience 1991;44:343-52.
57. Tomson T, Lindbom U, Nilsson BY. Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population. Epilepsia 1992;33:829-35.
58. Tomson T, Svanborg E, Wedlund JE. Nonconvulsive status epilepticus: high incidence of complex partial status. Epilepsia 1986;27:276-85.
59. Treiman DM, De Giorgio CMA, Salisbury SM, Wickboldt CL. Subtle generalized convulsive status epilepticus. Epilepsia 1984;25:653.
60. Treiman DM, Delgado-Escueta AV. Complex partial status epilepticus. In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ, eds. Advances in neurology. New York: Raven Press, 1983;34: 69-81.
61. Treiman DM, Delgado-Escueta AV, Clark MA. Impairment of memory following prolonged complex partial status epilepticus. Neurology 1981;31:109.
62. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998;339:792-8.
63. Voigt GC. Death following intravenous sodium diphenylhydantoin (Dilantin). Johns Hopkins Med J 1968;123:153-157.
64. Vuilleumier P, Despland PA, Regli F. Failure to recall (but not to remember): Pure transient amnesia during nonconvulsive status epilepticus. Neurology 1996;46:1036-9.
65. Walker, JE, Homan RW, Vasko MR, et al. Lorazepam in status epilepticus. Ann Neurol 1979;6:207-13.
66. Wasterlain CG, Fujikawa G, Penix L, et al. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993; 34:S37-S53.
67. Young GB, Jordan KG. Do nonconvulsive seizures damage the brain? - Yes. Arch Neurol 1998;55:117-19.